Articles tagged with: Combivir
Headline, News »
A study published last week in AIDS Patient Care and STDs found that Trizivir (zidovudine/lamivudine/abacavir) may help people with HIV simplify their long-term maintenance antiretroviral therapy (ART) routine, decreasing harmful side effects and making the drug regimen easier to follow.
However, the study authors caution that their results, which include only 48 weeks of trial data, are still preliminary. Longer follow-up periods will be necessary to ensure the regimen will be safe and effective long-term.
Currently, the standard treatment regimen for HIV includes at least three antiretroviral medications from two…
Headline, News »
A recent study published on the Web site PloS One implicates Combivir (zidovudine/lamivudine) in “limb fat loss,” a common side effect of treatment for HIV infection. In a clinical trial conducted by researchers in the Netherlands, Combivir-containing therapy was associated with localized loss of fat tissue and build up of internal fat tissue in the stomach. These findings support using alternatives to Combivir as preferred components of antiretroviral treatment.
Combivir (zidovudine/lamivudine) is a combination therapy that includes zidovudine (Retrovir) and Epivir (lamivudine). Both zidovudine and Epivir are nucleoside reverse transcriptase…